Cochlear implants "still pose meningitis risk"
This article was originally published in Clinica
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has updated its August 2002 guidance on the increased potential risk of pneumococcal meningitis among recipients of a cochlear implant, particularly among children. The MHRA cites research by the MRC Institute of Hearing Research, which found that "although the risk of cochlear implant patients contracting bacterial meningitis remains low, the risk among implanted adults is slightly higher than for the general population".
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.